By synthesizing information from the TCGA database related to ten established cancer signaling pathways, we discovered that classical tumor suppressor genes such as TP53, CNTN6, CREBBP, and EP300RB1 had a higher frequency of mutations in the high MLLS group. This evidence concerns the gene TP53 and cancer.